Variations in Serum Hemoglobin, Albumin, and Electrolytes in Patients Receiving Intravenous Immunoglobulin Therapy: A Real Clinical Threat?

Author： Mignogna Michele D.

Publisher： Adis International

ISSN： 1175-0561

Source： American Journal of Clinical Dermatology, Vol.8, Iss.5, 2007-01, pp. : 291-299

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Adjuvant High-Dose Intravenous Immunoglobulin Therapy Can Be Easily and Safely Introduced as an Alternative Treatment in Patients with Severe Pemphigus Vulgaris: A Retrospective Preliminary Study

By Michele Davide Mignogna

American Journal of Clinical Dermatology, Vol. 9, Iss. 5, 2008-01 ,pp. : 323-331

Adis International

Access to resources Recommend Favorite

Relevant Criteria for Selecting an Intravenous Immunoglobulin Preparation for Clinical Use

By Chérin Patrick

BioDrugs, Vol. 24, Iss. 4, 2010-08 ,pp. : 211-223

Adis International

Access to resources Recommend Favorite

Intravenous Immunoglobulin Use in Patients with Toxic Epidermal Necrolysis and Stevens-Johnson Syndrome

By Mittmann Nicole

American Journal of Clinical Dermatology, Vol. 7, Iss. 6, 2006-01 ,pp. : 359-368

Adis International

Access to resources Recommend Favorite

Modulating Effects of Intravenous Immunoglobulins on Serum Cytokine Levels in Patients with Primary Hypogammaglobulinemia

By Ibáñez Cristina

BioDrugs, Vol. 19, Iss. 1, 2005-01 ,pp. : 59-65

Adis International

Access to resources Recommend Favorite

Intravenous Immunoglobulin Therapy in Autoimmune Mucocutaneous Blistering Diseases: A Review of the Evidence for its Efficacy and Safety

By Gürcan Hakan M. Jeph Sunil Ahmed A. Razzaque

American Journal of Clinical Dermatology, Vol. 11, Iss. 5, 2010-10 ,pp. : 315-326

Adis International

Access to resources Recommend Favorite